Welcome to our dedicated page for CONCENTRA GROUP HOLDINGS PAREN news (Ticker: CON), a resource for investors and traders seeking the latest updates and insights on CONCENTRA GROUP HOLDINGS PAREN stock.
Concentra Group Holdings Parent, Inc. reports developments tied to its U.S. occupational health services business, including financial results, guidance, cash dividends, and operating updates. The company serves employers and workers through occupational health centers, onsite health clinics, direct-to-employer care, and Concentra Telemed.
Recurring news themes include medical center openings in regional markets, work injury care, physical therapy, drug testing, DOT physical exams, pre-placement exams, and telemedicine for minor work injuries. Company updates also cover leadership transitions, annual and quarterly reporting schedules, balance sheet commentary, and the expansion of Concentra's national occupational medicine network.
Concentra (NYSE: CON) reported Q1 2026 results and raised full-year guidance on May 7, 2026. Q1 revenue was $569.6M (+13.7% YoY), net income $52.3M (+28.7% YoY), Adjusted EBITDA $120.7M (+17.6% YoY), and patient visits totaled 3.42M (+6.7% YoY). The board declared a cash dividend of $0.0625 per share. Full-year 2026 guidance: revenue $2.275–2.375B, Adjusted EBITDA $460–480M, net leverage 3.0x, and Free Cash Flow $215–235M.
Concentra (NYSE: CON) announced that Dr. John Anderson, executive vice president and Chief Medical Officer, will retire at the end of 2026 after 33 years with the company. The company has begun a formal search for his successor and said Anderson will provide advisory support via a consulting arrangement.
Dr. Anderson served as CMO since 2014 and joined Concentra in 1993. Concentra reported about 13,000 colleagues, serving ~53,000 patients per business day across 628 centers and 411 onsite clinics as of December 31, 2025.
Concentra (NYSE: CON) will release first quarter 2026 results for the period ended March 31, 2026, on Thursday, May 7, 2026 after market close. The company will host a live conference call and webcast on Friday, May 8, 2026 at 9:00 a.m. ET.
Investors can access the live webcast via the company website and replay will be available afterward. Concentra supports care at 628 occupational centers, 411 onsite clinics and Concentra Telemed, serving about 53,000 patients per business day, with roughly 13,000 colleagues and affiliated clinicians (as of Dec 31, 2025).
Concentra (NYSE: CON) reported strong Q4 2025 and full‑year results: Q4 revenue $539.1M (+15.9%), Q4 net income $36.2M (+58.7%), and Q4 Adjusted EBITDA $95.3M (+22.9%). For FY2025, revenue was $2.163B (+13.9%), Adjusted EBITDA $431.9M (+14.6%), and Free Cash Flow $197.8M.
The company ended 2025 with 628 occupational centers, 411 onsite clinics, cash of $79.9M, total debt of $1,574.4M, and net leverage ~3.4x. 2026 guidance: revenue $2.25–2.35B; Adjusted EBITDA $450–470M; Free Cash Flow $200–225M.
Concentra (NYSE: CON) reported preliminary unaudited results for Q4 and FY2025 and provided full‑year 2026 guidance. Key 2025 metrics: FY revenue $2,163.4M (+13.9%), Adjusted EBITDA $431.9M (+14.6%), free cash flow $197.8M, capital expenditures $82.3M (+28%), and net leverage ~3.4x. Q4 revenue was $539.1M and Adj EBITDA $95.3M. For 2026 the company expects revenue $2.25–2.35B, Adjusted EBITDA $450–470M, free cash flow $200–225M, and target net leverage ≤3.0x. Full results will be released Feb 26, 2026 with a conference call Feb 27, 2026.
Concentra (NYSE: CON) announced the opening of a new medical center in Tucker, Georgia, located at 4434 Hugh Howell Road, Tucker, GA 30084 on January 26, 2026. The center will provide work injury care, physical therapy, drug testing, DOT and pre-placement exams, employer-related services, and telemedicine via Concentra Telemed. Concentra operates an extensive network—628 occupational health centers and 409 onsite clinics serving more than 50,000 patients daily as of September 30, 2025.
Concentra (NYSE: CON) announced the opening of a new medical center in Hialeah, Florida on December 15, 2025. The new Concentra Hialeah is located at 855 East 8th Avenue, Hialeah, FL 33010 and will offer work injury care, physical therapy, drug testing, DOT physicals, pre-placement exams and other employer-related health services.
The center will also provide telemedicine for minor work injuries via Concentra Telemed. The expansion adds to Concentra’s national footprint of 628 occupational health centers and 409 onsite clinics, serving more than 50,000 patients daily with approximately 13,000 colleagues as of September 30, 2025.
Concentra (NYSE: CON) opened a new occupational health center in Corona, California on December 8, 2025 at 629 North Main Street, Unit C-3, Corona, CA 92878.
The center will offer work injury care, physical therapy, drug testing, DOT and pre-placement exams, employer-related health services, and telemedicine via Concentra Telemed. Concentra operates an extensive network of occupational health sites, reporting 628 centers, 409 onsite clinics, and about 13,000 colleagues supporting >50,000 patient visits daily as of September 30, 2025.
Concentra (NYSE: CON) appointed Jason Cooper as Chief Data, Analytics, and Artificial Intelligence Officer on November 10, 2025. Cooper will lead data strategy, governance, technology enablement, and insight generation to align analytics and AI with enterprise growth priorities.
Cooper brings over 25 years of experience across private, for-profit, and nonprofit sectors, with prior roles at L3-Communications, MATRIC, CVS Caremark, Cigna, Blue Cross Blue Shield plans, HMS, and Paradigm Corp. He holds memberships with the Society for Information Management and is a Fellow of the American College of Health Data Management.
Concentra operates 628 occupational health centers and 413 onsite clinics, serving more than 50,000 patients daily as of September 30, 2025.
Concentra (NYSE: CON) reported strong third quarter 2025 results, announcing a cash dividend and a $100 million share repurchase authorization while raising full‑year 2025 guidance.
Key Q3 metrics: Revenue $572.8M (+17.0% YoY), Adjusted EBITDA $118.9M (+17.1% YoY), net income $49.8M, and 3,557,697 patient visits. Cash was $49.9M and net leverage improved to 3.6x at 9/30/2025. Board declared a $0.0625 per share dividend payable ~Dec 9, 2025, and authorized up to $100M repurchases through 12/31/2027.
Raised 2025 outlook: Revenue $2.145B–$2.160B, Adjusted EBITDA $425M–$430M, CapEx $80M–$90M, and target net leverage ≤3.5x by year-end 2025.